Non-interventional Observational Study to Evaluate the Efficacy and Safety of Non-immune Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice

National Society for Neurosonology and Cerebral Circulation2 个研究点分布在 2 个国家目标入组 336 人2023年2月1日

适应症Acute Stroke

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: Acute Stroke
发起方: National Society for Neurosonology and Cerebral Circulation
入组人数: 336
试验地点: 2
主要终点: Proportion of intracerebral hemorrhage
状态: 招募中
最后更新: 19天前

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

The study will collect data from aged 18 to 85 years with a diagnosis of acute stroke, who received thrombolytic treatment with a new agent, nonimmunogenic staphylokinase. Outcomes will be checked for safety and compared to the results of treatment with the other thrombolytic drug, alteplase.

注册库

clinicaltrials.gov

开始日期

2023年2月1日

结束日期

2030年5月10日

最后更新

19天前

研究类型

Observational

性别

All

研究者

发起方

National Society for Neurosonology and Cerebral Circulation

责任方

Sponsor

入排标准

入选标准

•Age 18-85 ;
•Diagnosis of acute ischemic stroke eligible for thrombolytic therapy;
•Thrombolytic therapy with the drug "non-immunogenic staphylokinase" is planned or has already been performed.

排除标准

•Individual intolerance or known hypersensitivity to a recombinant protein containing the amino acid sequence of staphylokinase;
•The presence of a contraindication to thrombolytic therapy of ischemic stroke;
•Pregnancy or lactation.